Inventor
MA FUPENG
US23 patents
⚠️ This page may combine multiple inventors who share the name “MA FUPENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
9 patentsUS7485722B2Feb 3, 2009
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
ASTRAZENECA AB29 citations92
US7799792B2Sep 21, 2010
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
ASTRAZENECA AB11 citations83
US7868008B2Jan 11, 2011
Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
ASTRAZENECA AB11 citations81
US7807706B2Oct 5, 2010
Metabotropic glutamate-receptor-potentiating isoindolones
ASTRAZENECA AB6 citations71
US8377940B2Feb 19, 2013
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842
ASTRAZENECA AB4 citations61
US7968570B2Jun 28, 2011
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
ASTRAZENECA AB6 citations60
US8377939B2Feb 19, 2013
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842
ASTRAZENECA AB0 citations51
US7790717B2Sep 7, 2010
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
ASTRAZENECA AB0 citations51
US7816354B2Oct 19, 2010
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
ASTRAZENECA AB0 citations40
ARTMAN III GERALD DAVID
6 patentsUS8501756B2Aug 6, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID65 citations96
US8242125B2Aug 14, 2012
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID3 citations61
US8541432B2Sep 24, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8492393B2Jul 23, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8486954B2Jul 16, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8431584B2Apr 30, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
NOVARTIS AG
6 patentsUS11185537B2Nov 30, 2021
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG6 citations81
US10844055B2Nov 24, 2020
Naphthyridinone derivatives and their use in the treatment of arrhythmia
NOVARTIS AG1 citations70
US11833142B2Dec 5, 2023
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG1 citations59
US11530213B2Dec 20, 2022
Naphthyridinone derivatives and their use in the treatment of arrhythmia
NOVARTIS AG0 citations59
US10266531B2Apr 23, 2019
Naphthyridinone derivatives and their use in the treatment of arrhythmia
NOVARTIS AG0 citations48
US11427586B2Aug 30, 2022
1,2,4-oxadiazole derivatives as liver X receptor agonists
NOVARTIS AG0 citations46